Multiple Soluble Components of the Glycocalyx Are Increased in Patient Plasma After Ischemic Stroke

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Brian DellaValle, Københavns Universitet
  • ,
  • Henrik Hasseldam, Københavns Universitet
  • ,
  • Flemming F. Johansen, Københavns Universitet
  • ,
  • Helle K. Iversen, Københavns Universitet
  • ,
  • Jørgen Rungby
  • Casper Hempel, Technical University of Denmark

Background and Purpose- The GLX (glycocalyx) is a protein/polysaccharide meshwork at the cellular surface. Consisting largely of glycosaminoglycans and proteoglycans, the GLX can shed in response to stress. In this study, we assay 11 components of the GLX in plasma from patients with ischemic stroke from a longitudinal cohort. Methods- Plasma samples from healthy individuals (N=8), and patients with ischemic stroke day ≥3, day 7, and day 90 (N=9-14) were immunoassayed for diverse components of the GLX. Results- Median stroke severity was mild (National Institutes of Health Stroke Scale 2.0 (range, 0-6) at day ≤3). Three (keratan-chondroitin-heparan-sulfate) of 4 glycosaminoglycans and CD44 (proteoglycan) were increased at day 7 and returned to baseline at day 90. Proteoglycan syndecan (Syn)-3 increased and Syn-2 levels decreased, significantly. Conclusions- Individual GLX components are often assayed as stand-alone biomarkers for endothelial health. This study suggests a full assessment of GLX components is more indicative of the endothelial health of an individual and represents a complex GLX signature that may be valuable as a composite biomarker of disease.

OriginalsprogEngelsk
TidsskriftStroke
Vol/bind50
Nummer10
Sider (fra-til)2948-2951
Antal sider4
ISSN0039-2499
DOI
StatusUdgivet - 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 167685241